伽马射线辐照鸡沙门菌口服疫苗在鸡模型中引发稳健的细胞与体液免疫应答
本研究从本地田间菌株制备伽马射线辐照鸡沙门菌(γ-SG)疫苗,7 kGy可抑制细菌复制并保留残余代谢活性。14日龄Ross 308肉鸡口服或肌内接种两次,口服γ-SG组3周后CD4+、CD8+ T细胞应答和IFN-γ浓度显著高于SG 9R、γ-SG肌内组和F-SG组,攻毒后口服γ-SG组死亡率为0%。
要点
- 7 kGy伽马射线辐照可灭活鸡沙门菌复制并保留残余代谢活性。
- 口服γ-SG组3周后CD4+ T细胞39.74%、CD8+ T细胞28.6%、IFN-γ 452.75 pg/mL,均高于其他疫苗组。
- 攻毒后口服γ-SG组死亡率0%,SG 9R组同样0%,F-SG组40%、γ-SG肌内组20%、未免疫组70%。
核心结论
- 无佐剂口服γ-SG疫苗是抗鸡伤寒的有效策略。
研究设计与样本
- 研究从本地田间菌株制备伽马射线辐照鸡沙门菌(γ-SG)疫苗,评估1.5至10 kGy辐照剂量以确定灭活复制同时保留代谢活性的最佳水平。
- 14日龄Ross 308商品肉鸡口服γ-SG、肌内注射油佐剂γ-SG、油佐剂甲醛灭活SG(F-SG)和SG 9R疫苗,间隔两周接种两次,每种疫苗浓度2×10^8 CFU、SG 9R为2×10^7 CFU,溶于0.2 mL PBS。
主要发现
- 7 kGy剂量有效抑制细菌复制并维持残余代谢活性。
- 接种后3周,口服γ-SG组CD4+ T细胞应答为39.74%,高于SG 9R组29.36%、γ-SG肌内组20.2%和F-SG组22.8%。
- 接种后3周,口服γ-SG组CD8+ T细胞应答为28.6%,高于SG 9R组5.28%、γ-SG肌内组19.7%和F-SG组14.3%。
- 口服γ-SG组IFN-γ浓度为452.75 pg/mL,高于SG 9R组307.5 pg/mL、γ-SG肌内组334 pg/mL和F-SG组221.75 pg/mL。
- 攻毒后口服γ-SG组保护率100%、死亡率0%,与SG 9R组相当;F-SG组死亡率40%、γ-SG肌内组20%,未免疫攻毒组70%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gamma-irradiated inactivated bacterial vaccines have emerged as a safer alternative, overcoming the safety and immunogenicity limitations of conventional live attenuated and inactivated vaccines. This study aimed to develop gamma-irradiated Salmonella Gallinarum (γ-SG) vaccine from a local field strain and evaluate its cell-mediated immune response in a chicken model, focusing on CD4+ and CD8+ T cell activation and IFN-γ production. Radiation doses ranging from 1.5 to 10 kGy were evaluated to determine the optimal level for inactivating bacterial replication while retaining metabolic activity. Dose of 7 kGy effectively inhibited replication while maintaining residual metabolic activity. In an immunization-challenge study, commercial broiler chickens (Ross 308) at 14 days of age were vaccinated twice at two-week intervals orally with γ-SG (γ-SG Oral), intramuscularly with oil-based γ-SG (γ-SG IM), oil-based formalin-inactivated SG (F-SG) and SG 9R vaccines with the concentration of each 2 × 108 CFU and SG 9R at the concentration of 2 × 107 CFU in 0.2 mL PBS. Our study showed that chickens vaccinated with γ-SG (Oral) exhibited significantly higher CD4+ T cell response (39.74 %) when compared with SG 9R (29.36 %), γ-SG (IM) (20.2 %) and F-SG (22.8 %) groups at three weeks post-vaccination (WPV). Similarly, CD8+ T cell response was highest in γ-SG (Oral) group (28.6 %) versus SG 9R (5.28 %), γ-SG (IM) (19.7 %), and F-SG (14.3 %) at 3WPV. IFN-γ concentrations were also significantly elevated in γ-SG (Oral) group (452.75 pg/mL) when compared with SG 9R (307.5 pg/mL), γ-SG (IM) (334 pg/mL), and F-SG (221.75 pg/mL) groups. In vivo efficacy study showed that γ-SG (Oral) provided 100 % protection with 0 % mortality, comparable to SG 9R while F-SG and γ-SG (IM) groups showed 40 % and 20 % mortality, respectively, compared to 70 % in unvaccinated chickens challenged with wild-type SG. These findings demonstrate that non-adjuvanted oral γ-SG vaccination is an effective strategy against fowl typhoid.
引用
- Ashraf M, Ghafoor A, Suleman M, et al. Gamma-irradiated Salmonella Gallinarum oral vaccine elicits robust cellular and humoral immune responses in a chicken model. Vaccine. 2025. PMID: 41046833. doi:10.1016/j.vaccine.2025.127833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。